Sebastian Matthews

Earlier-stage decisions may not make headlines, but they ultimately will set back vaccine R&D in ways that we'll continue to see for decades.

We saw during the COVID pandemic just how transformative a vaccine can be.

And there was momentum there, both for influenza and other potential pandemic diseases.

I think tariffs, I think immigration, I think the amount of governmental oversight cost associated with development and with construction, they are all big red flags.